October 27, 2023 – Page 9

OTC Markets Group Welcomes Senzime AB to OTCQX

Written by Customer Service on October 27, 2023. Posted in Public Companies.

NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced Senzime AB (Nasdaq Stockholm: SEZI; OTCQX: SNZZF), a Swedish medical device company, has qualified to trade on the OTCQX® Best Market. Senzime AB upgraded to OTCQX from the Pink® market. Senzime AB begins trading today on OTCQX under the symbol “SNZZF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information...

AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic

Written by Customer Service on October 27, 2023. Posted in Public Companies.

PRESS RELEASE AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic ACI-125891 delivers the first element of a precision medicine approach by enabling early and accurate diagnosis of a-syn pathology in certain diseases Clinical trial of ACI-12589 showed a specific and reproducible retention pattern in patients with MSA, a rare and difficult-to-diagnose neurodegenerative disease ACI-12589 promises to catalyze accelerated development and targeted treatment of MSA and other a-synucleinopathies such as genetic Parkinson’s disease (PD) Lausanne, Switzerland, October 27, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced the publication...

Fortis Inc. Releases Third Quarter 2023 Results

Written by Customer Service on October 27, 2023. Posted in Earnings Releases And Operating Results.

This news release constitutes a “Designated News Release” incorporated by reference in the prospectus supplement dated September 19, 2023 to Fortis’ short form base shelf prospectus dated November 21, 2022. ST. JOHN’S, Newfoundland and Labrador, Oct. 27, 2023 (GLOBE NEWSWIRE) — Fortis Inc. (“Fortis” or the “Corporation”) (TSX/NYSE: FTS), a well-diversified leader in the North American regulated electric and gas utility industry, released its third quarter results1. Highlights Third quarter net earnings of $394 million or $0.81 per common share, up from $326 million or $0.68 per common share in 2022 Adjusted net earnings per common share2 of $0.84, up from $0.71 in the third quarter of 2022 Released 2024-2028 capital plan of $25 billion, representing 6.3% average annualized rate...

Azimut Grants Stock Options

Written by Customer Service on October 27, 2023. Posted in Public Companies.

LONGUEUIL, Quebec, Oct. 27, 2023 (GLOBE NEWSWIRE) — Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) announces that on October 26, 2023, a total of 1,032,000 stock options were granted to directors, officers, employees, and consultants. Of this number, 910,000 have been granted to directors and officers and 122,000 to employees and consultants. These options have an exercise price of $0.95 per share and are exercisable for a 10-year period. About Azimut ExplorationAzimut is a leading mineral exploration company with a solid reputation for target generation and partnership development. The Company holds the largest mineral exploration portfolio in Quebec. Its wholly owned flagship, the Elmer Gold Project, is advancing to the initial resource stage in the James Bay region. Azimut also controls a strategic...

Chart Industries Reports Record 2023 Third Quarter Financial Results and Completes Divestiture of American Fan for $111 million

Written by Customer Service on October 27, 2023. Posted in Public Companies.

ATLANTA, Oct. 27, 2023 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NYSE: GTLS) today reported strong results for the third quarter ended September 30, 2023. Results shown are from continuing operations unless otherwise noted and exclude the Roots™ financial results for our ownership period of March 17, 2023 through the close of the divestiture on August 18, 2023. When referring to any 2022 comparative period, all metrics are proforma for the combined business of Chart and Howden. The following are included in continuing operations for the third quarter 2023: (a) We signed a definitive agreement on July 26, 2023 to sell our Cofimco fans business to PX3 Partners for $80 million, and this transaction is anticipated to close on October 31, 2023 (earlier than originally anticipated). For the third quarter 2023 and year-to-date...

Costamare Inc. Sets the Date for Its Third Quarter 2023 Results Release, Conference Call and Webcast

Written by Customer Service on October 27, 2023. Posted in Public Companies.

Earnings Release: Wednesday, November 1, 2023, Before Market OpensConference Call and Webcast: Wednesday, November 1, 2023, at 8:30 a.m. ET MONACO, Oct. 27, 2023 (GLOBE NEWSWIRE) — Costamare Inc. (NYSE:CMRE) announced today that it will release its results for the third quarter ended September 30, 2023 before the market opens in New York on Wednesday, November 1, 2023. Conference Call Details: On Wednesday, November 1, 2023 at 8:30 a.m. ET, Costamare’s management team will hold a conference call to discuss the financial results. Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 1-844-887-9405 (from the US), 0808-238-9064 (from the UK) or +1-412-317-9258 (from outside the US). Please quote “Costamare”. A replay of the conference call will be available until November 8, 2023....

trivago Announces Ratio Change under its American Depositary Share Program

Written by Customer Service on October 27, 2023. Posted in Dividend Reports And Estimates.

DÜSSELDORF, Germany, October 27, 2023 – trivago N.V. (NASDAQ: TRVG) announced today that its management board has approved a change of ratio in the Company’s American Depositary Share (“ADS”) program, comprising a change in the ratio of American Depositary Shares (the “ADSs”) to trivago class A shares (the “Shares”) from one (1) ADS representing one (1) Share, to one (1) ADS representing five (5) Shares (the “Ratio Change”). The effective date of the Ratio Change (the “Effective Date”) is expected to be November 7, 2023. Pursuant to the Ratio Change, as of the Effective Date, record holders who directly hold ADSs will be required to exchange their existing ADSs for new ADRs on the basis of one (1) new ADR for every five (5) existing ADSs surrendered. The Depositary will contact the Company’s ADS holders and arrange for the exchange...

Prime Medicine Presents First-ever Prime Editing Data in Non-human Primates Demonstrating Highly Efficient Ability of Prime Editors to Precisely Correct Disease-causing Mutation of GSD1b

Written by Customer Service on October 27, 2023. Posted in Public Companies.

Up to 83% of Hepatocytes (up to 50% whole liver) Precisely Edited for p.L358fs Mutation Following IV Infusion of Prime Editor in NHPs with No Safety Concerns Observed; Editing Well Above Anticipated Threshold Necessary to Reverse Disease Manifestations Up to 56% Whole Liver Editing Observed in Humanized GSD1b Mouse Model No Detectable Off-target Edits Observed Following Comprehensive in vitro Analysis Data Presented Today in an Oral Presentation at ESGCT 2023 CAMBRIDGE, Mass., Oct. 27, 2023 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology Company committed to delivering a new class of differentiated, one-time curative genetic therapies, today reported new preclinical data demonstrating the ability of liver-targeted Prime Editors to efficiently and precisely correct one of the most prevalent disease-causing...

Verano Opens MÜV™ Satellite Beach, Elevating the Company’s Retail Footprint to 72 Florida Dispensaries and 135 Locations Nationwide

Written by Customer Service on October 27, 2023. Posted in Public Companies.

Located at 106 Florida Highway A1A, MÜV Satellite Beach bolsters the Company’s retail presence in Brevard County, an area with more than 606,000 residents1 MÜV Satellite Beach joins nearby MÜV dispensaries in Titusville, Merritt Island and West Melbourne Verano’s active operations span 13 states, comprised of 135 dispensaries and 14 cultivation and processing facilities with more than 1 million square feet of cultivation capacity CHICAGO, Oct. 27, 2023 (GLOBE NEWSWIRE) — Verano Holdings Corp. (NEO: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the opening of MÜV Satellite Beach on Friday, October 27, the Company’s 72nd Florida dispensary and 135th location nationwide. MÜV Satellite Beach, located on 106 Florida Highway A1A, will be open Monday through Saturday from...

Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO

Written by Customer Service on October 27, 2023. Posted in Public Companies.

Dr. Megan Baldwin transitions to Founder, Chief Innovation Officer and remains on the Board of Directors Experienced pharmaceutical executives Dr. Frederic Guerard appointed as CEO and Peter Lang appointed as CFO, bringing complementary expertise to lead Opthea’s next phase of growth MELBOURNE, Australia, Oct. 27, 2023 (GLOBE NEWSWIRE) — Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that the company’s Chief Executive Officer, Dr. Megan Baldwin, will transition to Founder and Chief Innovation Officer, effective today, reflective of the company’s strategy to advance its US and global presence and commercialization strategy for sozinibercept (OPT-302). Concurrently, Opthea is pleased to announce...

Day: October 27, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice